Nov 14 (Reuters) - Reviva Pharmaceuticals Holdings, Inc.
RVPH.O :
* REVIVA PHARMACEUTICALS HOLDINGS, INC. REPORTS THIRD
QUARTER 2022
FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
* REVIVA PHARMACEUTICALS - AS OF SEPTEMBER 30, 2022, CO'S
CASH
TOTALED ABOUT $23.2 MILLION COMPARED TO ABOUT $29.7 MILLION AS
OF DECEMBER 31, 2021
* REVIVA - BELIEVES CO'S CASH AS OF SEPT 30, 2022 WILL BE
SUFFICIENT TO FUND CURRENT OPERATING PLANS THROUGH AT LEAST NOV
2023
* REVIVA PHARMACEUTICALS HOLDINGS, INC. - QTRLY LOSS PER
SHARE
$0.18
Source text for Eikon: ID:nGNX4ky56T
Further company coverage: RVPH.O
((Reuters.Briefs@thomsonreuters.com;))